The effect of selenium administration on restless leg syndrome treatment

Iranian Red Crescent Medical Journal

Volumn 14, Issue 1, 2012, Pages

  Rahimdel, A G ^a   Ayatollahi, P ^a   Zeinali, A ^a   Mehrabanian, N ^a   Mellat Ardekani, A ^a  

^a YAZD UNIVERSITY   (Iran)

Author keywords

Restless leg syndrome; Selenium; Treatment

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; PLACEBO; SELENIUM;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; QUESTIONNAIRE; RECOMMENDED DRUG DOSE; RESTLESS LEGS SYNDROME;

EID: 84855261951     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Wetter TC, Pollmächer T. Restless legs and periodic leg movements in sleep syndromes. J Neurol 1997; 244:S37-S45. [9112588] [http://dx.doi.org/10.1007/BF03160570]
2. Silber MH, Ehrenberg BL, Allen RP, Buchfuhrer MJ, Earley CJ, Hening WA, Rye DB; Medical Advisory Board of the Restless Legs Syndrome Foundation. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004; 79:916-922. [15244390] [http://dx.doi.org/10.4065/79.7.916]
3. Bayard M, Avonda T, Wadzinski J. Restless legs syndrome. Am Fam Physician 2008;78:235-240. [18697508]
4. Högl B, Paulus W, Clarenbach P, Trenkwalder C. Restless legs syndrome: Diagnostic assessment and the advantages and risks of dopaminergic treatment. J Neurol 2006; 253:IV22-IV28. [16944353] [http://dx.doi.org/10.1007/s00415-006-4005-3]
5. Desai AV, Cherkas LF, Spector TD, Williams AJ. Genetic influences in self-reported symptoms of obstructive sleep apnea and restless legs: a twin study. Twin Res 2004;7:589-595. [15607009] [http://dx.doi.org/10.1375/1369052042663841]
6. Chen S, Ondo WG, Rao S, Li L, Chen Q, Wang Q. Genomewide linkage scans identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004;74:876-885. [15077200] [http://dx.doi.org/10.1086/420772]
7. Winkelmann J, Muller-Myhsok B, Wittchen HU, Hock B, Prager M, Pfister H, Strohle A, Eisensehr I, Dichgans M, Gasser T, Trenkwalder C. Complex segregation analysis of restless legs syndrome provides evidence for an autosomal dominant mode of inheritance in early age at onset families. Ann Neurol 2002; 52:297-302. [12205641] [http://dx.doi.org/10.1002/ana.10282]
8. Bonati MT, Ferini-Strambi L, Aridon P, Oldani A, Zucconi M, Casari G. Autosomal dominant restless legs syndrome maps on chromosome 14q. Brain 2003;126:1485-1492. [12764067] [http://dx.doi.org/10.1093/brain/awg137]
9. Montagna P. The treatment of restless legs syndrome. Neurological Science 2007;28:S61-S66. [http://dx.doi.org/10.1007/s10072-007-0739-7]
10. Zucconi M, Manconi M, Ferini Strambi L. Aetiopathogenesis of restless legs syndrome. Neurological Science 2007;28:47-52. [http://dx.doi.org/10.1007/s10072-007-0737-9]
11. Mrowka M, Jöbges M, Berding G, Schimke N, Shing M, Odin P. Computerized movement analysis and beta-CIT-SPECT in patients with restless legs syndrome. J Neural Transm 2005;112:693-701. [15517434] [http://dx.doi.org/10.1007/s00702-004-0217-9]
12. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J; Restless Legs Syndrome Diagnosis and Epidemiology workshop at the National Institutes of Health; International Restless Legs Syndrome Study Group. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119. [14592341] [http:// dx.doi.org/10.1016/S1389-9457(03)00010-8]
13. Walters AS, LeBrocq C, Dhar A, Hening W, Rosen R, Allen RP, Trenkwalder C; International Restless Legs Syndrome Study Group. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132. [14592342] [http://dx.doi.org/10.1016/S1389-9457(02)00258-7]
14. Zafar KS, Siddiqui A, Sayeed I, Ahmad M, Salim S, Islam F. Dosedependent protective effect of selenium in rat model of Parkinson disease: neurobehavioral and neurochemical evidences. J Neurochem 2003;84:438-446. [12558963] [http:// dx.doi.org/10.1046/j.1471-4159.2003.01531.x]
15. Trenkwalder C, Hening WA, Montagna P, Oertel WH, Allen RP, Walters AS, Costa J, Stiasny-Kolster K, Sampaio C. Treatment of restless legs syndrome: An evidence-based review and implications for clinical practice. Mov Disord 2008;23:2267-2302. [18925578] [http://dx.doi.org/10.1002/mds.22254]
16. Kohrle J, Jakob F, Contempre B, Dumont JE. Selenium, the thyroid and the endocrine system. Endocr Rev 2005;26:944-984. [16174820] [http://dx.doi.org/10.1210/er.2001-0034]
17. Hogue DE. Selenium. J Dairy Sci 1970;53:1135-1137.[4918952] [http:// dx.doi.org/10.3168/jds.S0022-0302(70)86356-1]
18. Alizadeh M, Daneghian S, Ghaffari A, Ostadrahimi AR, Safaeiyan AR, Estakhri R, Pourghassem Gargari B. The effect of hypocaloric diet enriched in legumes with or without Larginine and selenium on anthropometric measures in central obese women. J Res Med Sci 2010; 15:331-343. [21526106]
19. Boskabadi H, Rezagholizade Omran F, Tara F, Rayman MP, Ghayour-Mobarhan M, Sahebkar A, Tavallaie S, Shakeri MT, Alamdari DH, Kiani M, Razavi BS, Oladi M, Ferns G. The Effect of Maternal Selenium Supplementation on Pregnancy Outcome and the Level of Oxidative Stress in Neonates. Iran Red Crescent Med J 2010;12:254-259.
20. Patrick L. Selenium biochemistry and cancer: a review of the literature. Altern Med Rev 2004;9:239-258. [15387717]
21. Ge K, Yang G. The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am J Clin Nutr 1993; 57:259S-263S. [8427200]
22. Diplock AT. Indexes of selenium in human populations. Am J Clin Nutr 1993; 57:256S-258S. [8427199]
23. Khan HA. Selenium partially reverses the depletion of striatal dopamine and its metabolites in MPTP-treated C57BL mice. Neurochem Int 2010; 57:489-491. [20619308] [http://dx.doi.org/10.1016/j.neuint.2010.06.020]
24. Talas ZS, Ozdemir I, Gok Y, Ates B, Yilmaz I. Role of selenium compounds on tyrosine hydroxylase activity, adrenomedullin and total RNA levels in hearts of rats. Regul Pept 2010;159:137-141. [19706312] [http://dx.doi.org/10.1016/j.regpep.2009.08.009]
25. Castaño A, Ayala A, Rodriguez- Gomez JA, de la Cruz CP, Revilla E, Cano J, Machado A. Increase in dopamine turnover and tyrosine hydroxylase enzyme in hippocampus of rats fed on low selenium diet. J Neurosci Res 1995;42:684-691. [8600301] [http://dx.doi.org/10.1002/jnr.490420511]
26. Tara F, Rayman MP, Boskabadi H, Ghayour-Mobarhan M, Sahebkar A, Alamdari DH, Razavi BS, Tavallaie S, Azimi-Nezhad M, Shakeri MT, Oladi M, Yazarlu O, Ouladan S, Sangani MT, Omran FR, Ferns G. Pro oxidant-antioxidant balance in pregnancy: a randomized doubleblind placebo-controlled trial of selenium supplementation. J Perinat Med 2010;38:473-478. [20629489] [http://dx.doi.org/10.1515/JPM.2010.068]
27. Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, Parnes HL, Minasian LM, Gaziano JM, Hartline JA, Parsons JK, Bearden JD 3rd, Crawford ED, Goodman GE, Claudio J, Winquist E, Cook ED, Karp DD, Walther P, Lieber MM, Kristal AR, Darke AK, Arnold KB, Ganz PA, Santella RM, Albanes D, Taylor PR, Probstfield JL, Jagpal TJ, Crowley JJ, Meyskens FL Jr, Baker LH, Coltman CA Jr. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39-51. [19066370] [http://dx.doi.org/10.1001/jama.2008.864]
28. Agarwal P, Griffith A, Costantino HR, Vaish N. Gabapentin enacarbil - clinical efficacy in restless legs syndrome. Neuropsychiatr Dis Treat 2010;6:151-158. [20505847] [http://dx.doi.org/10.2147/NDT.S5712]
29. Högl B, Oertel WH, Stiasny-Kolster K, Geisler P, Beneš H, García-Borreguero D, Trenkwalder C, Poewe W, Schollmayer E, Kohnen R. Treatment of moderate to severe restless legs syndrome: 2-year safety and efficacy of rotigotine transdermal patch. BMC Neurol 2010;10:86. [20920156] [http://dx.doi.org/10.1186/1471-2377-10-86]
30. Walters AS, Ondo WG, Dreykluft T, Grunstein R, Lee D, Sethi K; TREAT RLS 2 (Therapy with Ropinirole: Efficacy And Tolerability in RLS 2) Study Group. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004;19:1414-1423. [15390050] [http://dx.doi.org/10.1002/mds.20257]
31. Aizawa H, Aburakawa Y, Suzuki Y, Enomoto H, Makita Y, Kikuchi K, Kimura T, Yahara O. Treatment of Japanese restless legs syndrome patients with cabergoline. Intern Med 2006;45:453-455.[16679700] [http://dx.doi.org/10.2169/internalmedicine.45.1555]
32. Fulda S, Wetter TC. Where dopamine meets opioids: a meta-analysis of the placebo effect in restless legs syndrome treatment studies. Brain 2008;131:902-917. [17932100] [http://dx.doi.org/10.1093/brain/awm244]